Skip to main content

Juno Therapeutics Inc (NASDAQ:JUNO) Investor Investigation Over Possible Wrongdoing In Acquisition Announced

  • If you purchased shares of Juno Therapeutics Inc (NASDAQ:JUNO) and currently hold any of those NASDAQ:JUNO shares, you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

An investigation on behalf of investors, who currently hold shares of Juno Therapeutics Inc (NASDAQ:JUNO), was announced concerning whether the takeover of Juno Therapeutics Inc. by Celgene Corporation for $87 per share is unfair to NASDAQ:JUNO stockholders. The investigation by a law firm concerns whether certain officers and directors of Juno Therapeutics Inc breached their fiduciar...



You must register (for free) or login to view the entire investigation.